The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Myocardial Infarction

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Myocardial Infarction


Psychiatry related information on Myocardial Infarction


High impact information on Myocardial Infarction


Chemical compound and disease context of Myocardial Infarction


Biological context of Myocardial Infarction


Anatomical context of Myocardial Infarction


Gene context of Myocardial Infarction


Analytical, diagnostic and therapeutic context of Myocardial Infarction


  1. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Swedberg, K., Held, P., Kjekshus, J., Rasmussen, K., Rydén, L., Wedel, H. N. Engl. J. Med. (1992) [Pubmed]
  2. Body iron stores and the risk of coronary heart disease. Sempos, C.T., Looker, A.C., Gillum, R.F., Makuc, D.M. N. Engl. J. Med. (1994) [Pubmed]
  3. Cocaine-induced coronary-artery vasoconstriction. Lange, R.A., Cigarroa, R.G., Yancy, C.W., Willard, J.E., Popma, J.J., Sills, M.N., McBride, W., Kim, A.S., Hillis, L.D. N. Engl. J. Med. (1989) [Pubmed]
  4. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. Johannesson, M., Jönsson, B., Kjekshus, J., Olsson, A.G., Pedersen, T.R., Wedel, H. N. Engl. J. Med. (1997) [Pubmed]
  5. Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Rust, S., Walter, M., Funke, H., von Eckardstein, A., Cullen, P., Kroes, H.Y., Hordijk, R., Geisel, J., Kastelein, J., Molhuizen, H.O., Schreiner, M., Mischke, A., Hahmann, H.W., Assmann, G. Nat. Genet. (1998) [Pubmed]
  6. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Yusuf, S., Pepine, C.J., Garces, C., Pouleur, H., Salem, D., Kostis, J., Benedict, C., Rousseau, M., Bourassa, M., Pitt, B. Lancet (1992) [Pubmed]
  7. The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies To Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Dracup, K., Alonzo, A.A., Atkins, J.M., Bennett, N.M., Braslow, A., Clark, L.T., Eisenberg, M., Ferdinand, K.C., Frye, R., Green, L., Hill, M.N., Kennedy, J.W., Kline-Rogers, E., Moser, D.K., Ornato, J.P., Pitt, B., Scott, J.D., Selker, H.P., Silva, S.J., Thies, W., Weaver, W.D., Wenger, N.K., White, S.K. Ann. Intern. Med. (1997) [Pubmed]
  8. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Ferrara, A., Barrett-Connor, E., Shan, J. Circulation (1997) [Pubmed]
  9. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Schulze, M.B., Shai, I., Rimm, E.B., Li, T., Rifai, N., Hu, F.B. Diabetes (2005) [Pubmed]
  10. Alternative hormone replacement regimens: is there a need for further clinical trials? Welty, F.K. Curr. Opin. Lipidol. (2003) [Pubmed]
  11. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Helgadottir, A., Manolescu, A., Helgason, A., Thorleifsson, G., Thorsteinsdottir, U., Gudbjartsson, D.F., Gretarsdottir, S., Magnusson, K.P., Gudmundsson, G., Hicks, A., Jonsson, T., Grant, S.F., Sainz, J., O'Brien, S.J., Sveinbjornsdottir, S., Valdimarsson, E.M., Matthiasson, S.E., Levey, A.I., Abramson, J.L., Reilly, M.P., Vaccarino, V., Wolfe, M.L., Gudnason, V., Quyyumi, A.A., Topol, E.J., Rader, D.J., Thorgeirsson, G., Gulcher, J.R., Hakonarson, H., Kong, A., Stefansson, K. Nat. Genet. (2006) [Pubmed]
  12. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Wang, X., Ria, M., Kelmenson, P.M., Eriksson, P., Higgins, D.C., Samnegård, A., Petros, C., Rollins, J., Bennet, A.M., Wiman, B., de Faire, U., Wennberg, C., Olsson, P.G., Ishii, N., Sugamura, K., Hamsten, A., Forsman-Semb, K., Lagercrantz, J., Paigen, B. Nat. Genet. (2005) [Pubmed]
  13. Allele-specific repression of lymphotoxin-alpha by activated B cell factor-1. Knight, J.C., Keating, B.J., Kwiatkowski, D.P. Nat. Genet. (2004) [Pubmed]
  14. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., Samani, N.J., Gudmundsson, G., Grant, S.F., Thorgeirsson, G., Sveinbjornsdottir, S., Valdimarsson, E.M., Matthiasson, S.E., Johannsson, H., Gudmundsdottir, O., Gurney, M.E., Sainz, J., Thorhallsdottir, M., Andresdottir, M., Frigge, M.L., Topol, E.J., Kong, A., Gudnason, V., Hakonarson, H., Gulcher, J.R., Stefansson, K. Nat. Genet. (2004) [Pubmed]
  15. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. Lewis, H.D., Davis, J.W., Archibald, D.G., Steinke, W.E., Smitherman, T.C., Doherty, J.E., Schnaper, H.W., LeWinter, M.M., Linares, E., Pouget, J.M., Sabharwal, S.C., Chesler, E., DeMots, H. N. Engl. J. Med. (1983) [Pubmed]
  16. Reactivation of unstable angina after the discontinuation of heparin. Théroux, P., Waters, D., Lam, J., Juneau, M., McCans, J. N. Engl. J. Med. (1992) [Pubmed]
  17. The value of lowering cholesterol after myocardial infarction. Rossouw, J.E., Lewis, B., Rifkind, B.M. N. Engl. J. Med. (1990) [Pubmed]
  18. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. Ambrosioni, E., Borghi, C., Magnani, B. N. Engl. J. Med. (1995) [Pubmed]
  19. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). King, S.B., Lembo, N.J., Weintraub, W.S., Kosinski, A.S., Barnhart, H.X., Kutner, M.H., Alazraki, N.P., Guyton, R.A., Zhao, X.Q. N. Engl. J. Med. (1994) [Pubmed]
  20. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. Køber, L., Torp-Pedersen, C., Carlsen, J.E., Bagger, H., Eliasen, P., Lyngborg, K., Videbaek, J., Cole, D.S., Auclert, L., Pauly, N.C. N. Engl. J. Med. (1995) [Pubmed]
  21. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. Steingart, R.M., Packer, M., Hamm, P., Coglianese, M.E., Gersh, B., Geltman, E.M., Sollano, J., Katz, S., Moyé, L., Basta, L.L. N. Engl. J. Med. (1991) [Pubmed]
  22. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. Schömig, A., Kastrati, A., Dirschinger, J., Mehilli, J., Schricke, U., Pache, J., Martinoff, S., Neumann, F.J., Schwaiger, M. N. Engl. J. Med. (2000) [Pubmed]
  23. Effect of the haptoglobin phenotype on the size of a myocardial infarct. Chapelle, J.P., Albert, A., Smeets, J.P., Heusghem, C., Kulbertus, H.E. N. Engl. J. Med. (1982) [Pubmed]
  24. Coronary-artery spasm and myocardial infarction associated with cocaine use. Schachne, J.S., Roberts, B.H., Thompson, P.D. N. Engl. J. Med. (1984) [Pubmed]
  25. Acute myocardial infarction. Prognostic value of white blood cell count and blood glucose level. Modan, B., Schor, S., Shani, M. JAMA (1975) [Pubmed]
  26. Erythrocyte glutathione peroxidase and myocardial infarction. Gromadzińska, J., Skłodowska, M. JAMA (1990) [Pubmed]
  27. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. Kuhlmann, M.T., Kirchhof, P., Klocke, R., Hasib, L., Stypmann, J., Fabritz, L., Stelljes, M., Tian, W., Zwiener, M., Mueller, M., Kienast, J., Breithardt, G., Nikol, S. J. Exp. Med. (2006) [Pubmed]
  28. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. Bialik, S., Geenen, D.L., Sasson, I.E., Cheng, R., Horner, J.W., Evans, S.M., Lord, E.M., Koch, C.J., Kitsis, R.N. J. Clin. Invest. (1997) [Pubmed]
  29. The Werner syndrome protein is a DNA helicase. Gray, M.D., Shen, J.C., Kamath-Loeb, A.S., Blank, A., Sopher, B.L., Martin, G.M., Oshima, J., Loeb, L.A. Nat. Genet. (1997) [Pubmed]
  30. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., Nakaya, H., Yamauchi-Takihara, K., Komuro, I. Nat. Med. (2005) [Pubmed]
  31. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G.D., Cleutjens, J.P., Shipley, M., Angellilo, A., Levi, M., Nübe, O., Baker, A., Keshet, E., Lupu, F., Herbert, J.M., Smits, J.F., Shapiro, S.D., Baes, M., Borgers, M., Collen, D., Daemen, M.J., Carmeliet, P. Nat. Med. (1999) [Pubmed]
  32. Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients. Marciante, K.D., Bis, J.C., Rieder, M.J., Reiner, A.P., Lumley, T., Monks, S.A., Kooperberg, C., Carlson, C., Heckbert, S.R., Psaty, B.M. Am. J. Epidemiol. (2007) [Pubmed]
  33. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke. Marciante, K.D., Totah, R.A., Heckbert, S.R., Smith, N.L., Lemaitre, R.N., Lumley, T., Rice, K.M., Hindorff, L.A., Bis, J.C., Hartman, B., Psaty, B.M. Pharmacogenet. Genomics (2008) [Pubmed]
  34. Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion. Ong, L., Reiser, P., Coromilas, J., Scherr, L., Morrison, J. N. Engl. J. Med. (1983) [Pubmed]
  35. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. Collins, R., Peto, R., Baigent, C., Sleight, P. N. Engl. J. Med. (1997) [Pubmed]
  36. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. Weintraub, W.S., Boccuzzi, S.J., Klein, J.L., Kosinski, A.S., King, S.B., Ivanhoe, R., Cedarholm, J.C., Stillabower, M.E., Talley, J.D., DeMaio, S.J. N. Engl. J. Med. (1994) [Pubmed]
  37. Value and limitations of thallium-201 scintigraphy in the acute phase of myocardial infarction. Wackers, F.J., Sokole, E.B., Samson, G., Schoot, J.B., Lie, K.I., Liem, K.L., Wellens, H.J. N. Engl. J. Med. (1976) [Pubmed]
  38. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. Asinger, R.W., Mikell, F.L., Elsperger, J., Hodges, M. N. Engl. J. Med. (1981) [Pubmed]
WikiGenes - Universities